At the annual meeting of the American Urological Association early this morning in San Francisco, we we given the initial report on the results of the Men’s Eating and Living (MEAL) trial. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: active, diet, MEAL, surveillance, trial, vegetable | Leave a comment »
So one of the more interesting things to be announced since your sitemaster arrived at the annual meeting of the American Urological Association (AUA) in San Francisco yesterday was this one: … READ MORE …
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: active, Dendreon, Provenge, sipuleucel-T, surveillance, trial | Leave a comment »
A research letter in the Journal of the American Medical Association reports a major uptake in the application of active surveillance as a first-line form of management of prostate cancer across the Veterans Affairs health system here in the US since 2005. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active, Affairs, low risk, Management, surveillance, veterans | Leave a comment »
“Getting off biopsy train in prostate cancer” is the title of the latest article by Howard Wolinsky (a long-time active active surveillance patient) on the MedPage Today web site. We recommend it to your attention. … READ MORE …
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Risk | Tagged: active, cancer, Diagnosis, Management, proactive, risk, surveillance | 11 Comments »
Data from eight patients in a small clinical trial have suggested that stem-cell therapy may be able to restore erectile function in men treated for prostate cancer by radical prostatectomy. … READ MORE …
Filed under: Uncategorized | Tagged: cell, ED, erectile, function, stem, therapy | 2 Comments »
The following infographic was also issued today by the U.S. Preventive Services Task Force (USPSTF) and offers guidance as to the appropriateness of prostate cancer screening for an average, 55- to 69-year-old American male with no specific, known risk factors for prostate cancer: … READ MORE …
Filed under: Diagnosis, Risk | Tagged: cancer, infographic, prostate, risk, screening | 8 Comments »
